Francesco Bianchi Sells 3,500 Shares of LivaNova (NASDAQ:LIVN) Stock

Key Points

• Director Francesco Bianchi sold 3,500 LivaNova shares at an average price of $78.01, generating $273,035 and reducing his ownership by 44.11% to 4,434 shares. He had also sold 1,650 shares on August 31.
• LivaNova shares recently traded at $80.63, near their 52-week high of $85.76. The company exceeded quarterly earnings and revenue expectations, reporting $1.26 in EPS and $390.59 million in revenue, with revenue up 10.8% year over year.
• Analysts maintain a generally positive outlook, with six Buy ratings and five Holds producing a consensus “Moderate Buy” rating and an average price target of $84.12. Institutional investors own 97.64% of the company.

LivaNova PLC (NASDAQ:LIVN - Get Free Report) Director Francesco Bianchi sold 3,500 shares of the company's stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $78.01, for a total transaction of $273,035.00. Following the completion of the transaction, the director owned 4,434 shares of the company's stock, valued at approximately $345,896.34. The trade was a 44.11% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Francesco Bianchi also recently made the following trade(s):

• On Monday, August 31st, Francesco Bianchi sold 1,650 shares of LivaNova stock. The shares were sold at an average price of $79.72, for a total transaction of $131,538.00.

LivaNova Price Performance

Shares of LIVN traded up $2.45 during trading hours on Monday, reaching $80.63. 551,807 shares of the stock traded hands, compared to its average volume of 750,927. The company has a current ratio of 1.45, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. LivaNova PLC has a 52-week low of $48.82 and a 52-week high of $85.76. The company's 50-day moving average price is $80.35 and its two-hundred day moving average price is $73.36. The company has a market cap of $4.44 billion, a P/E ratio of 23.86 and a beta of 0.87.

LivaNova (NASDAQ:LIVN - Get Free Report) last issued its earnings results on Thursday, August 6th. The company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.09 by $0.17. LivaNova had a net margin of 12.82% and a return on equity of 16.35%. The company had revenue of $390.59 million during the quarter, compared to the consensus estimate of $380.50 million. During the same quarter in the prior year, the firm posted $1.05 EPS. LivaNova's quarterly revenue was up 10.8% compared to the same quarter last year. On average, analysts anticipate that LivaNova PLC will post 3.77 earnings per share for the current year.

Institutional Trading of LivaNova

Institutional investors and hedge funds have recently modified their holdings of the stock. Maverick Capital Ltd. purchased a new position in shares of LivaNova during the first quarter valued at $956,000. Renaissance Technologies LLC raised its holdings in shares of LivaNova by 15.7% in the first quarter. Renaissance Technologies LLC now owns 183,000 shares of the company's stock valued at $11,631,000 after acquiring an additional 24,900 shares in the last quarter. Rhenman & Partners Asset Management AB lifted its stake in LivaNova by 258.5% in the fourth quarter. Rhenman & Partners Asset Management AB now owns 190,000 shares of the company's stock worth $11,691,000 after acquiring an additional 137,000 shares during the period. Hsbc Holdings PLC lifted its stake in LivaNova by 260.6% in the fourth quarter. Hsbc Holdings PLC now owns 20,301 shares of the company's stock worth $1,255,000 after acquiring an additional 14,671 shares during the period. Finally, Quantinno Capital Management LP grew its holdings in LivaNova by 263.8% during the 1st quarter. Quantinno Capital Management LP now owns 55,562 shares of the company's stock worth $3,532,000 after acquiring an additional 40,289 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on LIVN shares. Mizuho lifted their price objective on LivaNova from $90.00 to $95.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 15th. Zacks Research downgraded shares of LivaNova from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 19th. Weiss Ratings raised shares of LivaNova from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, August 18th. Needham & Company LLC boosted their target price on LivaNova from $81.00 to $93.00 and gave the company a "buy" rating in a research report on Wednesday, August 5th. Finally, KeyCorp upped their target price on LivaNova from $83.00 to $92.00 and gave the company an "overweight" rating in a research note on Monday, June 22nd. Six investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, LivaNova presently has a consensus rating of "Moderate Buy" and an average price target of $84.12.

LivaNova Company Profile

LivaNova PLC NASDAQ: LIVN is a medical device company that develops and manufactures technologies for the treatment of neurological and cardiovascular conditions. The company serves hospitals, physicians and patients in markets around the world, with operations and commercial activities spanning North America, Europe and other international markets.

LivaNova's Neuromodulation business produces vagus nerve stimulation (VNS) systems marketed under the VNS Therapy brand. These implantable devices are used as an adjunctive treatment for drug-resistant epilepsy and are designed to deliver programmed electrical stimulation to the vagus nerve.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.